Dr. Jason M. Alter is the Head of Scientific Affairs for Exosome Diagnostics. He has extensive experience in prognostic and predictive testing in Urologic Oncology. He has played key roles in the development of prostate cancer assays (biopsy and post-radical prostatectomy) at multiple companies. Dr. Alter has published on genomic and non-genomic risk assessment methods for prostate cancer and is very familiar with available molecular and genomic testing for the disease. Dr. Alter has a dual B.A. in Biology and History from Alfred University, an M.S. degree in Immuno-Parasitology from Texas A&M University, and a Ph.D. in Molecular Biology from Binghamton University. He did a postdoctoral fellowship at Schering Plough Pharmaceuticals. In this episode, Dr. Geo and Dr. Alter discuss the effectiveness of urine tests in identifying prostate cancer.